3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
23 23 0 1 0 0 0 0 0999 V2000
-0.3046 2.1640 -0.3696 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.7542 0.8049 0.3144 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2788 -0.0292 -0.0959 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.4361 -2.0130 -0.3212 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8947 0.0748 -0.2072 C 0 0 2 0 0 0 0 0 0 0 0 0
-0.3580 0.8610 0.2098 C 0 0 2 0 0 0 0 0 0 0 0 0
-1.6275 0.1523 -0.2685 C 0 0 1 0 0 0 0 0 0 0 0 0
0.7773 -1.3959 0.2163 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6338 -1.3186 0.1437 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1634 0.6997 0.3782 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9898 0.1096 -1.3025 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.3977 0.9901 1.2992 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.7296 0.2426 -1.3571 H 0 0 0 0 0 0 0 0 0 0 0 0
1.6354 -1.9698 -0.1511 H 0 0 0 0 0 0 0 0 0 0 0 0
0.7858 -1.4888 1.3097 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.7311 -1.4140 1.2329 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.5226 -1.8099 -0.2697 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.4042 -1.9739 -1.3402 H 0 0 0 0 0 0 0 0 0 0 0 0
2.1561 0.6646 1.4727 H 0 0 0 0 0 0 0 0 0 0 0 0
2.2825 1.7394 0.0598 H 0 0 0 0 0 0 0 0 0 0 0 0
0.3452 2.6857 0.1304 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.7182 1.7401 0.0497 H 0 0 0 0 0 0 0 0 0 0 0 0
4.0733 0.3780 0.2892 H 0 0 0 0 0 0 0 0 0 0 0 0
1 6 1 0 0 0 0
1 21 1 0 0 0 0
2 7 1 0 0 0 0
2 22 1 0 0 0 0
3 10 1 0 0 0 0
3 23 1 0 0 0 0
4 8 1 0 0 0 0
4 9 1 0 0 0 0
4 18 1 0 0 0 0
5 6 1 0 0 0 0
5 8 1 0 0 0 0
5 10 1 0 0 0 0
5 11 1 0 0 0 0
6 7 1 0 0 0 0
6 12 1 0 0 0 0
7 9 1 0 0 0 0
7 13 1 0 0 0 0
8 14 1 0 0 0 0
8 15 1 0 0 0 0
9 16 1 0 0 0 0
9 17 1 0 0 0 0
10 19 1 0 0 0 0
10 20 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
(3R,4R,5R)-5-(hydroxymethyl)piperidine-3,4-diol
4.2 InChl
InChI=1S/C6H13NO3/c8-3-4-1-7-2-5(9)6(4)10/h4-10H,1-3H2/t4-,5-,6-/m1/s1
4.3 InChlKey
QPYJXFZUIJOGNX-HSUXUTPPSA-N
4.4 Canonical SMILES
C1C(C(C(CN1)O)O)CO
4.5 lsomeric SMILES
C1[C@@H]([C@H]([C@@H](CN1)O)O)CO
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病